Aroda VR, Jorgensen NB, Kumar B, Lingvay I, et al. High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial. Diabetes Care 2025 Apr 25:dc242425. doi: 10.2337/dc24-2425.
PMID: 40279144